Tennis star is one of many players who have tried positive for the banned medication meldonium.
Russian tennis star Maria Sharapova is to confront a hostile to doping board on Wednesday subsequent to testing positive for a banned medication in January.
The five-times great hammer champion declared in March that she had fizzled a test for meldonium at the Australian Open.
Meldonium - Latvian-made heart prescription - was added to the World Anti-Doping Agency's (WADA) banned rundown on January 1.
Sharapova said she had been taking meldonium on her specialist's requests for a long time and that she didn't know that the drug had been banned.
The 29-year-old was temporarily suspended on March 12 pending the hearing.
The greatest discipline accessible is four years, however most against doping specialists think a boycott of six to 12 months is more probable.
Several competitors have tried positive for meldonium this year and there has been much open deliberation encompassing the medication
WADA conceded a month ago that their bans may be toppled because of an absence of clear experimental data on to what extent the medication stays in the body.
What is meldonimum?
Meldonium is utilized restoratively to treat heart issues like angina and myocardial localized necrosis. It is likewise a powerful treatment for ischemia - or absence of blood stream.
In game, it is said to advantage competitors by expanding their stamina and continuance.
It is made in Latvia and most normally utilized as a part of Russia and it is not endorsed by the Food and Drug Administration for use in the US.